Christian Belmant

USPTO Granted Patents = 14 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 81(Granted Patents)

Location History:

Blagnac, FR (2003 - 2006)
Six-Fours-lès-Plages, FR (2018)
Six-Fours-les-Plages, FR (2008 - 2020)

Company Filing History:

Paul Scherrer Institut

patents

5 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

5. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2020

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10675359 - Enzymatic conjugation of antibodies (2020-06-09),

2. 10434180 - Enzymatic conjugation of polypeptides (2019-10-08),

3. 10132799 - Screening of conjugated antibodies (2018-11-20),

4. 9764038 - Enzymatic conjugation of antibodies (2017-09-19),

5. 9717803 - Enzymatic conjugation of polypeptides (2017-08-01),

6. 9427478 - Enzymatic conjugation of polypeptides (2016-08-30),

7. 7767842 - Class of γδ T cells activators and use thereof (2010-08-03),

8. 7683045 - Class of γδ T cells activators and use thereof (2010-03-23),

9. 7625879 - Phosphohalohydrins, process for the production thereof and use thereof (2009-12-01),

10. 7432253 - Phosphoepoxides, method for making same and uses (2008-10-07),

11. 7109183 - Phosphohalohydrins, process for the production thereof and use thereof (2006-09-19),

12. 7101711 - Phosphoepoxides, method for making same and uses (2006-09-05),

13. 6660723 - Phosphalohydrins and methods for medicinal administration (2003-12-09),

14. 6624151 - Compounds selectively inhibiting gamma 9 delta 2 T lymphocytes (2003-09-23),

Title: Christian Belmant: Innovator in Antibody Functionalization

Introduction

Christian Belmant is a prominent inventor based in Six-Fours-les-Plages, France. He has made significant contributions to the field of immunology, particularly in the functionalization of antibodies. With a total of 14 patents to his name, Belmant's work has the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents, Belmant has developed methods for the enzymatic conjugation of antibodies. This application focuses on the functionalization of immunoglobulins, specifically with drugs. It also includes the disclosure of linking reagents, functionalized antibodies, pharmaceutical compositions, and methods for treating diseases and conditions. Another notable patent involves the enzymatic conjugation of polypeptides, which similarly addresses the functionalization of immunoglobulins with drugs and includes related linking reagents and pharmaceutical compositions.

Career Highlights

Throughout his career, Christian Belmant has worked with esteemed organizations such as Innate Pharma and the Paul Scherrer Institut. His experience in these institutions has allowed him to refine his expertise in antibody research and development.

Collaborations

Belmant has collaborated with notable colleagues, including Patrick Dennler and Delphine Bregeon. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christian Belmant is a key figure in the field of antibody functionalization, with a robust portfolio of patents that reflect his innovative contributions. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.